Development of a mouse model for chronic cat allergen-induced asthma

International Archives of Allergy and Immunology

Volumn 165, Issue 3, 2014, Pages 195-205

  Grundström, Jeanette ^a   Saarne, Tiiu ^a   Kemi, Cecilia ^b,c   Gregory, Joshua A ^b,c   Wadén, Konrad ^a   Pils, Marina C ^d   Adner, Mikael ^b,c   Gafvelin, Guro ^a,b   Van Hage, Marianne ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c Centre for Allergy Research   (Sweden)

^d HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

Author keywords

Allergy; Asthma; Cat allergen; Fel d 1; Mouse model

Indexed keywords

ALLERGEN; ALUMINUM POTASSIUM SULFATE; CAT ALLERGEN; IMMUNOGLOBULIN E ANTIBODY; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN G2A ANTIBODY; INTERLEUKIN 17; INTERLEUKIN 4; INTERLEUKIN 5; MESSENGER RNA; METHACHOLINE; OVALBUMIN; UNCLASSIFIED DRUG; ANTIBODY; CYTOKINE; FEL D 1 PROTEIN, FELIS DOMESTICUS; GLYCOPROTEIN; RECOMBINANT PROTEIN;

AIRWAY; ALLERGIC ASTHMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; DANDER; EOSINOPHIL; FEMALE; LUNG CHARACTERISTICS AND FUNCTIONS; LUNG COMPLIANCE; LUNG LAVAGE; LUNG PARENCHYMA; LUNG TISSUE REMODELLING; LYMPHOCYTE; MOUSE; MOUSE MODEL; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY TRACT ALLERGY; RESPIRATORY TRACT INFLAMMATION; AIRWAY REMODELING; ANIMAL; ASTHMA; BAGG ALBINO MOUSE; BLOOD; BRONCHUS HYPERREACTIVITY; CAT; CELL CULTURE; DISEASE MODEL; HUMAN; IMMUNIZATION; IMMUNOLOGY; METABOLISM;

AIRWAY REMODELING; ANIMALS; ANTIBODIES; ASTHMA; BRONCHIAL HYPERREACTIVITY; CATS; CELLS, CULTURED; CYTOKINES; DANDER; DISEASE MODELS, ANIMAL; EOSINOPHILS; FEMALE; GLYCOPROTEINS; HUMANS; IMMUNIZATION; LYMPHOCYTES; MICE; MICE, INBRED BALB C; NEUTROPHILS; RECOMBINANT PROTEINS;

EID: 84920008488     PISSN: 10182438     EISSN: 14230097     Source Type: Journal    
DOI: 10.1159/000369066     Document Type: Article

References (41)

1. Abramson MJ, Puy RM, Weiner JM: Injection allergen immunotherapy for asthma. Cochrane Database Syst Rev 2010;8:CD001186.
2. Niggemann B, Jacobsen L, Dreborg S, Ferdousi HA, Halken S, Host A, Koivikko A, Koller D, Norberg LA, Urbanek R, Valovirta E, Wahn U, Moller C: Five-year follow-up on the PAT study: specific immunotherapy and long-term prevention of asthma in children. Allergy 2006; 61: 855-859.
3. Calderon MA, Demoly P, Gerth van Wijk R, et al: EAACI: a European declaration on immunotherapy-designing the future of allergen specific immunotherapy. Clin Transl Allergy 2012; 2: 20.
4. Casale TB, Stokes JR: Future forms of immunotherapy. J Allergy Clin Immunol 2011; 127: 8-17.
5. Valenta R, Campana R, Marth K, van Hage M: Allergen-specific immunotherapy: from therapeutic vaccines to prophylactic approaches. J Intern Med 2012; 272: 144-157.
6. Kumar RK, Herbert C, Foster PS: The 'classical' ovalbumin challenge model of asthma in mice. Curr Drug Targets 2008; 9: 485-494.
7. Kumar RK, Foster PS: Modeling allergic asthma in mice: pitfalls and opportunities. Am J Respir Cell Mol Biol 2002; 27: 267-272.
8. Kips JC, Anderson GP, Fredberg JJ, Herz U, Inman MD, Jordana M, Kemeny DM, Lotvall J, Pauwels RA, Plopper CG, Schmidt D, Sterk PJ, van Oosterhout AJ, Vargaftig BB, Chung KF: Murine models of asthma. Eur Respir J 2003; 22: 374-382.
9. Fuchs B, Braun A: Improved mouse models of allergy and allergic asthma-chances beyond ovalbumin. Curr Drug Targets 2008; 9: 495-502.
10. McMillan SJ, Lloyd CM: Prolonged allergen challenge in mice leads to persistent airway remodelling. Clin Exp Allergy 2004; 34: 497-507.
11. Johnson JR, Wiley RE, Fattouh R, Swirski FK, Gajewska BU, Coyle AJ, Gutierrez-Ramos JC, Ellis R, Inman MD, Jordana M: Continuous exposure to house dust mite elicits chronic airway inflammation and structural remodeling. Am J Respir Crit Care Med 2004; 169: 378-385.
12. Wang Y, Li Y, Shan J, Fixman E, McCusker C: Effective treatment of experimental ragweedinduced asthma with STAT-6-IP, a topically delivered cell-penetrating peptide. Clin Exp Allergy 2011; 41: 1622-1630.
13. Goplen N, Karim MZ, Liang Q, Gorska MM, Rozario S, Guo L, Alam R: Combined sensitization of mice to extracts of dust mite, ragweed, and aspergillus species breaks through tolerance and establishes chronic features of asthma. J Allergy Clin Immunol 2009; 123: 925-932.e911.
14. Kerzerho J, Maazi H, Speak AO, Szely N, Lombardi V, Khoo B, Geryak S, Lam J, Soroosh P, van Snick J, Akbari O: Programmed cell death ligand 2 regulates T H 9 differentiation and induction of chronic airway hyperreactivity. J Allergy Clin Immunol 2013; 131: 1048-1057.e2.
15. Chen ZG, Zhang TT, Li HT, Chen FH, Zou XL, Ji JZ, Chen H: Neutralization of TSLP inhibits airway remodeling in a murine model of allergic asthma induced by chronic exposure to house dust mite. PLoS One 2013; 8:e51268.
16. Kumar RK, Herbert C, Webb DC, Li L, Foster PS: Effects of anticytokine therapy in a mouse model of chronic asthma. Am J Respir Crit Care Med 2004; 170: 1043-1048.
17. McMillan SJ, Xanthou G, Lloyd CM: Therapeutic administration of budesonide ameliorates allergen-induced airway remodelling. Clin Exp Allergy 2005; 35: 388-396.
18. Fattouh R, Midence NG, Arias K, Johnson JR, Walker TD, Goncharova S, Souza KP, Gregory RC Jr, Lonning S, Gauldie J, Jordana M: Transforming growth factor-β regulates house dust mite-induced allergic airway inflammation but not airway remodeling. Am J Respir Crit Care Med 2008; 177: 593-603.
19. Schou C: Defining allergens of mammalian origin. Clin Exp Allergy 1993; 23: 7-14.
20. Plaschke P, Janson C, Norrman E, Bjornsson E, Ellbjar S, Jarvholm B: Association between atopic sensitization and asthma and bronchial hyperresponsiveness in Swedish adults: pets, and not mites, are the most important allergens. J Allergy Clin Immunol 1999; 104: 58-65.
21. Ronmark E, Bjerg A, Perzanowski M, Platts-Mills T, Lundback B: Major increase in allergic sensitization in schoolchildren from 1996 to 2006 in northern Sweden. J Allergy Clin Immunol 2009; 124: 357-363, 363.e1-15.
22. Gronlund H, Adedoyin J, Reininger R, Varga EM, Zach M, Fredriksson M, Kronqvist M, Szepfalusi Z, Spitzauer S, Gronneberg R, Valenta R, Hedlin G, van Hage M: Higher immunoglobulin E antibody levels to recombinant Fel d 1 in cat-Allergic children with asthma compared with rhinoconjunctivitis. Clin Exp Allergy 2008; 38: 1275-1281.
23. Gronlund H, Saarne T, Gafvelin G, van Hage M: The major cat allergen, Fel d 1, in diagnosis and therapy. Int Arch Allergy Immunol 2010; 151: 265-274.
24. Neimert-Andersson T, Thunberg S, Swedin L, Wiedermann U, Jacobsson-Ekman G, Dahlen SE, Scheynius A, Gronlund H, van Hage M, Gafvelin G: Carbohydrate-based particles reduce allergic inflammation in a mouse model for cat allergy. Allergy 2008; 63: 518-526.
25. Saarne T, Neimert-Andersson T, Gronlund H, Jutel M, Gafvelin G, van Hage M: Treatment with a Fel d 1 hypoallergen reduces allergic responses in a mouse model for cat allergy. Allergy 2011; 66: 255-263.
26. Grundstrom J, Neimert-Andersson T, Kemi C, Nilsson OB, Saarne T, Andersson M, van Hage M, Gafvelin G: Covalent coupling of vitamin D3 to the major cat allergen Fel d 1 improves the effects of allergen-specific immunotherapy in a mouse model for cat allergy. Int Arch Allergy Immunol 2012; 157: 136-146.
27. Thunberg S, Neimert-Andersson T, Cheng Q, Wermeling F, Bergstrom U, Swedin L, Dahlen SE, Arner E, Scheynius A, Karlsson MC, Gafvelin G, van Hage M, Gronlund H: Prolonged antigen-exposure with carbohydrate particle based vaccination prevents allergic immune responses in sensitized mice. Allergy 2009; 64: 919-926.
28. Gronlund H, Bergman T, Sandstrom K, Alvelius G, Reininger R, Verdino P, Hauswirth A, Liderot K, Valent P, Spitzauer S, Keller W, Valenta R, van Hage-Hamsten M: Formation of disulfide bonds and homodimers of the major cat allergen Fel d 1 equivalent to the natural allergen by expression in Escherichia coli . J Biol Chem 2003; 278: 40144-40151.
29. Bhakta NR, Woodruff PG: Human asthma phenotypes: from the clinic, to cytokines, and back again. Immunol Rev 2011; 242: 220-232.
30. Zhao J, Lloyd CM, Noble A: Th17 responses in chronic allergic airway inflammation abrogate regulatory T-cell-mediated tolerance and contribute to airway remodeling. Mucosal Immunol 2013; 6: 335-346.
31. Fogli LK, Sundrud MS, Goel S, Bajwa S, Jensen K, Derudder E, Sun A, Coffre M, Uyttenhove C, van Snick J, Schmidt-Supprian M, Rao A, Grunig G, Durbin J, Casola S, Rajewsky K, Koralov SB: T cell-derived IL-17 mediates epithelial changes in the airway and drives pulmonary neutrophilia. J Immunol 2013; 191: 3100-3111.
32. Duechs MJ, Tilp C, Tomsic C, Gantner F, Erb KJ: Development of a novel severe triple allergen asthma model in mice which is resistant to dexamethasone and partially resistant to TLR7 and TLR9 agonist treatment. PLoS One 2014; 9:e91223.
33. Holgate ST, Davies DE, Powell RM, Howarth PH, Haitchi HM, Holloway JW: Local genetic and environmental factors in asthma disease pathogenesis: chronicity and persistence mechanisms. Eur Respir J 2007; 29: 793-803.
34. Renne R, Brix A, Harkema J, Herbert R, Kittel B, Lewis D, March T, Nagano K, Pino M, Rittinghausen S, Rosenbruch M, Tellier P, Wohrmann T: Proliferative and nonproliferative lesions of the rat and mouse respiratory tract. Toxicol Pathol 2009; 37: 5S-73S.
35. Hammad H, Chieppa M, Perros F, Willart MA, Germain RN, Lambrecht BN: House dust mite allergen induces asthma via Tolllike receptor 4 triggering of airway structural cells. Nat Med 2009; 15: 410-416.
36. Traidl-Hoffmann C, Mariani V, Hochrein H, Karg K, Wagner H, Ring J, Mueller MJ, Jakob T, Behrendt H: Pollen-Associated phytoprostanes inhibit dendritic cell interleukin-12 production and augment T helper type 2 cell polarization. J Exp Med 2005; 201: 627-636.
37. Eisenbarth SC, Piggott DA, Huleatt JW, Visintin I, Herrick CA, Bottomly K: Lipopolysaccharide-enhanced, Toll-like receptor 4-dependent T helper cell type 2 responses to inhaled antigen. J Exp Med 2002; 196: 1645-1651.
38. Kim YK, Oh SY, Jeon SG, Park HW, Lee SY, Chun EY, Bang B, Lee HS, Oh MH, Kim YS, Kim JH, Gho YS, Cho SH, Min KU, Kim YY, Zhu Z: Airway exposure levels of lipopolysaccharide determine type 1 versus type 2 experimental asthma. J Immunol 2007; 178: 5375-5382.
39. Kim YS, Hong SW, Choi JP, Shin TS, Moon HG, Choi EJ, Jeon SG, Oh SY, Gho YS, Zhu Z, Kim YK: Vascular endothelial growth factor is a key mediator in the development of T cell priming and its polarization to type 1 and type T helper cells in the airways. J Immunol 2009; 183: 5113-5120.
40. Natarajan S, Kim J, Bouchard J, Cruikshank W, Remick DG: Pulmonary endotoxin tolerance protects against cockroach allergen-induced asthma-like inflammation in a mouse model. Int Arch Allergy Immunol 2012; 158: 120-130.
41. Herre J, Gronlund H, Brooks H, Hopkins L, Waggoner L, Murton B, Gangloff M, Opaleye O, Chilvers ER, Fitzgerald K, Gay N, Monie T, Bryant C: Allergens as immunomodulatory proteins: the cat dander protein Fel d 1 enhances TLR activation by lipid ligands. J Immunol 2013; 191: 1529-1535.